Traws Pharma, Inc. (TRAW) — 10-Q Filings
All 10-Q filings from Traws Pharma, Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Traws Pharma Swings to Profit on Revenue Surge, Warrant Gains
— Aug 14, 2025 Risk: high
Traws Pharma, Inc. (TRAW) reported a significant turnaround in its financial performance for the six months ended June 30, 2025, achieving a net income of $20,5 -
Traws Pharma Files Q1 2025 10-Q
— May 15, 2025 Risk: medium
Traws Pharma, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information and disclosures related to its operations. Nota -
Traws Pharma Files Q3 2024 10-Q
— Nov 14, 2024 Risk: medium
Traws Pharma, Inc. filed its quarterly report for the period ending September 30, 2024. The company, formerly known as Onconova Therapeutics, Inc., is in the ph -
Traws Pharma Files Q2 2024 10-Q
— Aug 15, 2024 Risk: medium
Traws Pharma, Inc. filed its 10-Q for the period ending June 30, 2024. The company, formerly known as Onconova Therapeutics, Inc., is in the pharmaceutical prep -
Traws Pharma, Inc. Files 10-Q for Period Ending March 31, 2024
— May 15, 2024 Risk: low
Traws Pharma, Inc. (TRAW) filed a Quarterly Report (10-Q) with the SEC on May 15, 2024. Traws Pharma, Inc. (TRAW) filed a 10-Q report for the period ending Marc
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX